Urinary Incontinence is a medical condition which involves involuntary loss of urine. Incontinence can be either leakage of few drops of urine or complete emptying of the bladder. Urinary incontinence is a common complaint worldwide and causes embarrassment and distress. Prevalence of urinary incontinence varies based on type of incontinence and population studies. Urinary incontinence is more common among women than men, and women experience twice the symptoms of urinary incontinence than men. Aged women experience urinary incontinence more often than younger women. Factors responsible for high prevalence of urinary incontinence in women are pregnancy, childbirth, menopause, and structure of female urinary tract. Incontinence occurs because of issues related to muscles and nerves that help to release or hold the urine. The common symptoms associated with urinary incontinence is urgency, frequency, nocturia, dysuria, and nocturnal enuresis.
Obtain Report Details @
The global urinary incontinence treatment device market is driven by increase in geriatric population. The geriatric population is more prone to the problem of micturition due to high incidence of prostate hypertrophy where the inflamed prostate impairs bladder emptying. This increases pressure in the bladder which can weaken bladder muscles and result in an unstable bladder, leading to incontinence. Rising prevalence of diseases such as Parkinson’s and multiple sclerosis which damage the nerves that control the bladder function is driving the urinary incontinence devices market. High incidence of overactive bladder disorder which leads to urinary incontinence also contributes to rising demand for urinary incontinence devices. Advancements in technology and initiatives by key players to develop low cost devices to meet the rising demand for urinary incontinence treatment are propelling the global urinary incontinence treatment devices market.
The global urinary incontinence treatment devices market has been categorized based on type of urinary incontinence, product type, end-user, and region. In terms of type of urinary incontinence, the market has been segmented into stress incontinence (urine leaks when pressure is experienced by bladder during exercise, coughing, sneezing, or lifting heavy objects), urge incontinence (leakage of large amount of urine at unexpected time), overflow incontinence (unexpected leakage of urine due to full bladder), and mixed incontinence (usually due to stress and urge incontinence together). Stress incontinence is the most common type of urinary incontinence due to large population suffering from stress incontinence. It is more common among women due to physical changes occurring as a result of pregnancy, childbirth, and menopause which often result into stress incontinence. Urge incontinence is second most common type of urinary incontinence due to high prevalence of neurological diseases. Based on product type, the market has been segmented into pessary, tampons, occlusive devices, electrical stimulation devices, Foley catheters, urethral bulking agents, and others. In terms of end-user, the market has been segmented into hospitals, ambulatory surgical centers, specialty clinics, and others.
Geographically, the global urinary incontinence treatment devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share of the urinary incontinence treatment devices market. Rising prevalence of urinary incontinence, increase in geriatric population, growing awareness about symptoms and diagnosis of urinary incontinence, high health care expenditure, and favorable reimbursement scenario are factors attributed to the growth of the urinary incontinence treatment devices market in North America. Europe and Asia Pacific represent fast-growing markets due to rising geriatric population, high prevalence of neurological diseases, high incidence of stress related disorders, and increase in urinary incontinence patient population.
Key players in the global urinary incontinence treatment devices market are Promedon, C. R. Bard Inc., Boston Scientific Corporation, Ethicon US, LLC., Cook Medical, Inc., Precision Medical Devices, Johnson & Johnson, NeoTract, Inc., American Medical Solutions, and Coloplast Corp., among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Fill the form for an exclusive sample of this report @
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Browse market research blog: